March 9, 2017 / 9:41 PM / 4 months ago

BRIEF-KemPharm Q4 loss per share $0.68

1 Min Read

March 9 (Reuters) - Kempharm Inc:

* Kempharm, Inc reports fourth quarter and year end 2016 results

* Q4 loss per share $0.68

* Kempharm Inc - based on current forecast, existing resources are expected to fund operating expenses and capital expenditure requirements through Q2 2019

* Q4 earnings per share view $-0.70 -- Thomson Reuters I/B/E/S Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below